8.57
price down icon16.06%   -1.64
after-market After Hours: 1.95 -6.62 -77.25%
loading

Applied Therapeutics Inc Stock (APLT) Forecast

The Applied Therapeutics Inc (APLT) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $15.05, representing a +75.66% increase from the current price of $8.57. The highest analyst price target is $20.96, and the lowest is $9.1482.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month APLT Price Target
Average 30.70 (+258.25% Upside)
loading

Is Applied Therapeutics Inc (APLT) A Buy Now?

Oscillators
Name Value Action
RSI(14) 44.51 Neutral
STOCH(9,6) 52.26 Neutral
STOCHRSI(14) 67.64 Neutral
MACD(12,26) 0.1832 Sell
ADX(14) 25.08 Buy
William %R -91.94 Buy
CCI(14) -48.35 Neutral
Buy: 2 Sell: 1 Neutral: 4
Summary: Neutral
Moving Averages
Period Simple Exponential
MA10
9.1975
Sell
9.3226
Sell
MA20
9.3668
Sell
9.2335
Sell
MA50
8.809
Sell
8.5886
Sell
MA100
7.2487
Buy
7.5959
Buy
MA200
6.1995
Buy
6.2116
Buy
Buy: 4 Sell: 6 Neutral: 0
Summary: Sell
According to our latest analysis, APLT could be considered a Moderate Sell, with 17 technical analysis indicators signaling 6 Buy signals, 7 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on APLT, as trading bearish markets can be challenging and may result in losses.
  1. RSI (Relative Strength Index): The RSI(14) value of 44.51 indicates that APLT is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 52.26 indicates that APLT is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 67.64 indicates that APLT is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 25.08 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -48.35 indicates that APLT is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.

Long-term APLT price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Applied Therapeutics Inc financial reports and earnings history, Applied Therapeutics Inc (APLT) stock could reach $2.1667 by 2030, $7.5949 by 2040 and $16.70 by 2050. See the projected annual prices until 2050 of the Applied Therapeutics Inc stock below:

  • Applied Therapeutics Inc (APLT) is expected to reach an average price of $3.0766 in 2035, with a high prediction of $3.4291 and a low estimate of $3.4026. This indicates an $-64.10% rise from the last recorded price of $8.57.
  • Applied Therapeutics Inc (APLT) stock is projected to chart a bullish course in 2040, with an average price target of $7.8049, representing an $-8.93% surge from its current level. The forecast ranges from a conservative $7.9085 to a sky-high $7.5949.
  • Our analysts predict Applied Therapeutics Inc (APLT) to jump 51.42% by 2045, soaring from $13.05 to an average price of $12.98, potentially reaching $13.18. While $13.05 is the low estimate, the potential upside is significant.
  • Applied Therapeutics Inc (APLT) stock is expected to climb by 2050, reaching an average of $16.83, a $96.33% jump from its current level. However, a wide range of estimates exists, with high and low targets of $16.70 and $16.64, respectively, highlighting the market's uncertainty.

Applied Therapeutics Inc Stock (APLT) Year by Year Forecast

Applied Therapeutics Inc Stock (APLT) Price Forecast for 2024

Our forecast for APLT stock price in 2024 now indicates an average price target of $11.40 with a high forecast of $20.96 and a low forecast of $1.85. The average prediction reflects an increase of +33.08% from the last recorded price of $8.57.
Month Average Low High Change from today's price
December, 2024 $16.01 $9.1482 $20.96 +86.81%

Applied Therapeutics Inc Stock (APLT) Price Forecast for 2025

Applied Therapeutics Inc Stock (APLT) is expected to reach an average price of $31.59 in 2025, with a high prediction of $52.26 and a low estimate of $10.93. This indicates an +268.65% rise from the last recorded price of $8.57.
Month Average Low High Change from today's price
January, 2025 $35.34 $16.08 $40.42 +312.41%
February, 2025 $45.97 $34.04 $52.26 +436.35%
March, 2025 $36.05 $32.91 $48.86 +320.63%
April, 2025 $26.45 $13.39 $34.74 +208.65%
May, 2025 $30.75 $27.47 $42.97 +258.85%
June, 2025 $42.58 $29.62 $46.68 +396.80%
July, 2025 $30.44 $29.48 $47.05 +255.18%
August, 2025 $23.50 $21.72 $32.32 +174.23%
September, 2025 $24.41 $19.03 $28.52 +184.81%
October, 2025 $19.50 $17.53 $23.97 +127.50%
November, 2025 $15.30 $14.07 $22.44 +78.52%
December, 2025 $11.83 $10.93 $19.79 +38.06%

Applied Therapeutics Inc Stock (APLT) Price Forecast for 2026

The predicted value for Applied Therapeutics Inc (APLT) in 2026 is set at an average of $17.10. Estimates vary from a peak of $25.29 to a trough of $8.9024, indicating an +99.50% surge from the present price of $8.57.
Month Average Low High Change from today's price
January, 2026 $18.66 $8.9227 $19.90 +117.79%
February, 2026 $17.72 $14.68 $21.90 +106.73%
March, 2026 $15.19 $14.78 $19.59 +77.24%
April, 2026 $17.23 $14.98 $25.29 +101.08%
May, 2026 $15.40 $11.77 $18.32 +79.75%
June, 2026 $11.99 $11.69 $15.72 +39.87%
July, 2026 $12.76 $9.3502 $15.22 +48.89%
August, 2026 $18.13 $12.37 $20.11 +111.58%
September, 2026 $15.35 $14.83 $21.29 +79.06%
October, 2026 $11.85 $10.96 $16.70 +38.25%
November, 2026 $11.75 $9.4793 $14.81 +37.11%
December, 2026 $13.54 $8.9024 $13.66 +58.03%

Applied Therapeutics Inc Stock (APLT) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Applied Therapeutics Inc (APLT) is $7.5687, with a high forecast of $15.04 and a low forecast of $0.0926. This indicates an -11.68% decrease from the last price of $8.57.
Month Average Low High Change from today's price
January, 2027 $10.66 $9.3254 $15.04 +24.34%
February, 2027 $6.8484 $6.1884 $12.34 -20.09%
March, 2027 $5.8614 $4.7708 $7.8596 -31.61%
April, 2027 $0.7661 $0.0926 $5.942 -91.06%
May, 2027 $1.5637 $1.2655 $1.0937 -81.75%
June, 2027 $2.2507 $1.7831 $1.9707 -73.74%
July, 2027 $1.5183 $1.6483 $1.7701 -82.28%
August, 2027 $1.7858 $1.4877 $1.6958 -79.16%
September, 2027 $2.2628 $1.9952 $2.1334 -73.60%
October, 2027 $2.8151 $2.5121 $2.4604 -67.15%
November, 2027 $2.588 $2.7171 $2.6993 -69.80%
December, 2027 $2.0849 $2.2949 $2.5429 -75.67%

Applied Therapeutics Inc Stock (APLT) Price Forecast for 2028

In 2028, Applied Therapeutics Inc (APLT) is projected to reach an average price of $2.2205, with a high projection of $2.7715 and a low estimate of $1.6695. This indicates an -74.09% fall from the last price of $8.57.
Month Average Low High Change from today's price
January, 2028 $2.0625 $2.2137 $2.1131 -75.93%
February, 2028 $2.86 $2.1819 $2.4709 -66.63%
March, 2028 $2.7002 $2.7078 $2.7715 -68.49%
April, 2028 $2.2647 $2.5347 $2.5265 -73.57%
May, 2028 $2.5716 $2.499 $2.5016 -69.99%
June, 2028 $2.0792 $2.2592 $2.371 -75.74%
July, 2028 $2.2268 $2.1979 $2.1174 -74.02%
August, 2028 $2.2416 $2.2645 $2.2338 -73.84%
September, 2028 $2.3153 $2.3905 $2.3125 -72.98%
October, 2028 $1.5189 $1.6695 $2.1508 -82.28%
November, 2028 $1.5959 $1.7183 $1.7056 -81.38%
December, 2028 $1.6535 $1.6747 $1.6235 -80.71%

Applied Therapeutics Inc Stock (APLT) Price Forecast for 2029

The 2029 price forecast for Applied Therapeutics Inc Stock (APLT) is $3.3959 on average, with a high prediction of $6.7902 and a low estimate of $0.00166. This represents an -60.37% decrease from the previous price of $8.57.
Month Average Low High Change from today's price
January, 2029 $1.1804 $1.3161 $1.5649 -86.23%
February, 2029 $1.588 $1.537 $1.478 -81.47%
March, 2029 $0.1756 $1.0356 $1.5673 -97.95%
April, 2029 $0.3332 $0.5032 $0.3038 -96.11%
May, 2029 $0.7901 $0.3834 $0.5401 -90.78%
June, 2029 $0.3723 $0.5177 $0.6595 -95.66%
July, 2029 $0.4453 $0.0471 $1.7247 -94.80%
August, 2029 $0.3777 $0.1534 $0.5671 -95.59%
September, 2029 $4.5202 $0.00166 $6.7902 -47.26%
October, 2029 $4.2532 $2.792 $5.1278 -50.37%
November, 2029 $1.7756 $1.6606 $4.1638 -79.28%
December, 2029 $1.1288 $1.4488 $2.1968 -86.83%

Applied Therapeutics Inc Stock (APLT) Price Forecast for 2030

Applied Therapeutics Inc Stock (APLT) is expected to reach an average price of $23.86 in 2030, with a high forecast of $47.12 and a low forecast of $0.5909. This signifies an +178.37% surge from the last price of $8.57.
Month Average Low High Change from today's price
January, 2030 $2.7927 $1.3676 $2.1667 -67.41%
February, 2030 $2.1979 $2.3879 $2.1625 -74.35%
March, 2030 $1.123 $2.3104 $1.5855 -86.90%
April, 2030 $1.4332 $1.3206 $0.8318 -83.28%
May, 2030 $0.0279 $0.7521 $0.7942 -99.67%
June, 2030 $6.3827 $0.5909 $9.8303 -25.52%
July, 2030 $10.79 $3.4951 $15.72 +25.89%
August, 2030 $16.85 $8.04 $18.33 +96.66%
September, 2030 $38.07 $13.65 $42.85 +344.21%
October, 2030 $29.81 $27.81 $47.12 +247.84%
November, 2030 $20.37 $8.3181 $34.60 +137.68%
December, 2030 $32.96 $18.50 $37.94 +284.65%
$18.94
price down icon 1.35%
$75.45
price up icon 0.87%
$43.39
price up icon 3.19%
$378.13
price up icon 0.30%
$206.16
price up icon 7.31%
$120.72
price up icon 1.84%
Cap:     |  Volume (24h):